Waters Corporation (WAT) Financials

WAT Assets vs Liabilities

DateAssetsLiabilities
March 31, 2026 24.5 billion 9.2 billion
Dec. 31, 2025 5.1 billion 2.5 billion
Sept. 30, 2025 4.9 billion 2.5 billion
June 30, 2025 4.7 billion 2.6 billion

WAT Free Cash Flow and Stock based compensation

Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -42.0 million 20.0 million
Dec. 31, 2025 125.6 million 14.5 million
Sept. 30, 2025 161.9 million 13.7 million
June 30, 2025 18.5 million 13.1 million

WAT Net Income

Graph available only for paid members. Upgrade to see it.
DateNet Income
March 31, 2026 -72.0 million
Dec. 31, 2025 225.2 million
Sept. 30, 2025 148.9 million
June 30, 2025 147.1 million

WAT Cash and Debt

Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 462.0 million 5.2 billion -
Dec. 31, 2025 587.8 million 1.4 billion 83.6 million
Sept. 30, 2025 459.1 million 947.2 million 79.0 million
June 30, 2025 367.2 million 1.2 billion 81.4 million

WAT Shares Outstanding

Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 82.1 million
Dec. 31, 2025 59.8 million
Sept. 30, 2025 59.6 million
June 30, 2025 59.7 million

WAT Expenses

Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 39.0 million 96.0 million 394.0 million -
Dec. 31, 2025 39.0 million 50.1 million 196.7 million -
Sept. 30, 2025 25.4 million 53.6 million 214.2 million -
June 30, 2025 22.6 million 48.5 million 201.3 million -

WAT Cost of Revenue

Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 1.3 billion 672.0 million
Dec. 31, 2025 932.4 million 374.9 million
Sept. 30, 2025 799.9 million 327.8 million
June 30, 2025 771.3 million 321.4 million

WAT Revenue by Segment

Graph available only for paid members. Upgrade to see it.

WAT

Price: $379.77

52 week price:
275.05
414.15

Payout Ratio Range:
-39.25%
293.23%

Earnings Per Share: 7.85 USD

P/E Ratio: 44.34

Exchange: NYQ

Sector: Healthcare

Industry: Diagnostics & Research

Country: United States

Volume: 305400

Ebitda: 257.9 million

Market Capitalization: 34.2 billion

Links: